Skip to main content
BAX logo

BAX · Baxter International Inc

Track BAX — free
Market Cap
$13.35B
Shares
517.00M

BAX metrics

79 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$25.83
Market cap
$13.35B

Price action

19 metrics
Price change (1W)
-1.1%
Price change (30D)
-7.0%
Price change (3M)
+33.3%
Price change (6M)
+46.0%
Price change (YTD)
+35.2%
Price change (1Y)
+9.5%
Trailing year
Price change (5Y)
-68.8%
52-week high
$28.35
52-week low
$15.80
Change from 52-week high
-8.9%
Change from 52-week low
+63.5%
Annualized volatility
43.4%
Beta
1.2
RSI (14D)
51.0
Price vs SMA 50
+4.5%
Price vs SMA 200
+27.0%
Avg volume (3M)
6.52M
Relative volume
0.5
Average dollar volume
$155.43M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
517.00M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
1.2×
reciprocal yield 85.9%
P / book
2.2
reciprocal yield 46.5%
FCF yield
TTM · current market cap
Buyback yield
0.0%
P / FCF
P / operating cash flow
10.1
reciprocal yield 9.9%
Earnings yield
-8.0%

Historical valuation

8 metrics
P / E historical average (3Y)
37.0×
reciprocal yield 2.7%
P / E historical average (5Y)
38.9×
reciprocal yield 2.6%
EV / revenue historical average (3Y)
2.0×
reciprocal yield 49.2%
EV / revenue historical average (5Y)
2.5×
reciprocal yield 40.4%
EV / EBIT historical average (3Y)
301.8×
reciprocal yield 0.3%
EV / EBIT historical average (5Y)
171.7×
reciprocal yield 0.6%
EV / EBITDA historical average (3Y)
22.3×
reciprocal yield 4.5%
EV / EBITDA historical average (5Y)
21.2×
reciprocal yield 4.7%

Dividends & buybacks

7 metrics
Dividend yield
0.2%
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
$0.04
Dividend growth YoY
-94.1%
Dividend growth streak
Last ex-dividend
2026-08-28

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
30.1%
Operating margin
-2.4%
Trailing 12 months
Net margin
-9.3%
Gross profit (TTM)
$3.45B
Operating profit (TTM)
−$274.00M
Net income (TTM)
−$1.06B
Trailing 12 months
Diluted EPS (TTM)
$-2.09
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share

Growth

11 metrics
Revenue growth YoY
+5.3%
Year over year
Net income growth YoY
+38.5%
Revenue (TTM)
$11.47B
Trailing 12 months
EPS growth YoY
+33.3%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+3.8%
Revenue CAGR (5Y)
-0.7%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
-26.4%
FCF CAGR (5Y)
-22.1%

Quality

14 metrics
Return on equity
-17.1%
Return on assets
-5.4%
Debt / equity
Current ratio
1.9
EBITDA (TTM)
$679.00M
Free cash flow (TTM)
Quick ratio
1.3
Interest coverage
-0.9
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$2.15B
Total assets
$19.79B
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.32B
Capital expenditures (TTM)
$441.00M
R&D (TTM)
$512.00M
SG&A (TTM)
$2.93B
Stock compensation (TTM)
$115.00M
R&D / revenue
4.5%
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
697
13F filer change QoQ
+26
Institutional ownership
108.9%

Short interest

3 metrics
Short interest
4.6%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 10456 CUSIP 071813109 13F (30d) 330 filings 327 filers Visit website Investor relations